5. Culturally Competent Care for Substance Users Diagnosed with HIV Disease
Impact of Substance Use on HAART Adherence
Providing culturally appropriate care for HIV-positive substance users will require familiarity with some core background issues that are common to patients from all racial/ethnic populations.
Historically, HIV-positive substance users have been considered to be more likely to experience poorer virologic and clinical outcomes compared to HIV-positive patients who are not substance users. There is limited evidence that some drugs of abuse may directly affect HIV pathogenesis and immune response.[Kapadia 2005, Madden 2002] More importantly, however, the primary effect of drug abuse on HIV disease progression is due to factors that may limit patients’ access or adherence to HAART, thereby resulting in poorer outcomes. Nevertheless, studies have demonstrated that substance abusers who adhere to therapy are likely to experience outcomes similar to those of treatment-adherent patients who are not substance abusers. This underscores the importance of carefully integrated therapy for both substance abuse and HIV disease in the management of HIV-positive drug abusers, so that adherence to HAART and HIV treatment outcomes are optimized.[Celentano 2007, Nijhawan 2008]
Increasing HIV Testing Among Substance Users
Increased access to HIV testing among substance users has been shown to result in more users receiving HAART.[Wood 2006] And to increase access to testing will require that it be provided in alternative settings in addition to traditional healthcare environments, which are underutilized by substance users, due—among other factors—to lack of insurance, involvement with the criminal justice system, and fear of stigmatization. Substance-use treatment and prevention programs, however, can expand the opportunities to engage substance users in care and to enhance HIV testing.
In many localities, expanding testing opportunities will necessitate alternative policy strategies, such as those involving:
- Providing HIV testing and counseling services in substance use treatment facilities
- Harm-reduction programs like needle and syringe exchange programs
- Access to medical treatments like methadone and buprenorphine [JAMA 2010]
In addition, fewer than 17% of US substance users who require treatment for substance use in fact access treatment programs [SAMHSA 2008 Results], suggesting that alternative testing and treatment sites could be beneficial. One large group of such sites is correctional facilities, where 60% to 70% of incarcerated persons have a substance-use disorder and HIV prevalence is significant. [Spaulding 2009] Introduction of standardized HIV testing and care practices throughout US correctional facilities could contribute to reaching more HIV-positive substance users with vital HIV testing and access to care, which will also benefit their communities upon release. [Volkow 2010]
Expanded efforts to identify, test, and provide access to effective care for both substance use and HIV disease for HIV-positive substance users in both effective substance-use and HIV treatment offer the chance to achieve 3 key goals:
- Decrease substance use
- Reduce HIV-related morbidity and mortality
- Reduce HIV transmission rates and thereby overall HIV incidence
Studies in a variety of population groups have shown that the availability of HIV testing and provision of effective disease management are critical tools not only in enhancing individual health outcomes but also in reducing HIV transmission and community viral load. [Montaner 2006, Wood 2009] Doing so in the population of HIV-positive substance users is a key part of the success of the overall effort against these overlapping epidemics. Moreover, provision of appropriate, effective care for members of the affected populations—eg, substance users of diverse racial/ethnic groups and men who have sex with men—will involve customizing testing and access to care programs in accordance with the particular cultural needs of each population.